alexa
Reach Us +44-1647-403003
Cell-Based Targeting of Anti-Cancer Nanotherapy to Tumors | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Cell-Based Targeting of Anti-Cancer Nanotherapy to Tumors

Deryl Troyer*

Department of Anatomy and Physiology, Kansas State University, Manhattan, KS66506, USA

*Corresponding Author:
Deryl Troyer
Department of Anatomy and Physiology
Kansas State University, Manhattan, KS66506, USA
Tel: 785-532-4509
Fax: 785-532-4557
E-mail: [email protected]

Received date: March 07, 2013; Accepted date: March 28, 2013; Published date: March 30, 2013

Citation: Troyer D (2013) Cell-Based Targeting of Anti-Cancer Nanotherapy to Tumors. J Cancer Sci Ther 5: 142-143. doi: 10.4172/1948-5956.1000200

Copyright: © 2013 Troyer D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

There is emerging and convincing data that certain cells, administered systemically, have a natural propensity to migrate to cancerous tissues in preclinical models. Examples of such cells include neural stem cells, bone marrow mesenchymal stem cells, umbilical cord Wharton’s jelly stem cells [3], and defensive cells.This homing ability can be exploited by using cells as stealth vehicles to ferry therapeutic nanomaterials to tumors to facilitate penetration, reduce potential toxicity, reduce potential unwanted immune consequences, and reduce removal by the reticuloendothelial system (RES).

Recommended Conferences
Share This Page
Top